✦ LIBER ✦

Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses

✍ Scribed by Sigurveig Th. Sigurdardottir; Katrin Davidsdottir; Vilhjalmur A. Arason; Olof Jonsdottir; France Laudat; William C. Gruber; Ingileif Jonsdottir

Book ID: 116960650
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 786 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.05.072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of CRM197 conj

Immunogenicity and safety of CRM197 conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants

✍ Eric Mallet; Elisabeth Brachet; Philip Fernsten; France Laudat; Ahmad Razmpour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 266 KB

A randomized study comparing the safety

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide—CRM197 with a meningococcal group C conjugate vaccine in healthy infants: Challenge phase

✍ Anna Riddell; Jim P. Buttery; Jodie McVernon; Tracey Chantler; Laura Lane; Jane 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Immunogenicity of one, two or three dose

Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine

✍ J. Southern; A. Crowley-Luke; R. Borrow; N. Andrews; E. Miller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 93 KB